Skip to main content
Premium Trial:

Request an Annual Quote

ChromaCode Receives FDA Emergency Use Authorization for SARS-CoV-2 PCR Test

NEW YORK – Software and reagent technology firm ChromaCode announced Wednesday its HDPCR SARS-CoV-2 Real-Time PCR assay received Emergency Use Authorization from the US Food and Drug Administration.

The test detects the virus from nasopharyngeal swab specimens and runs on standard qPCR instruments, including Thermo Fisher Scientific's Applied Biosystems 7500 Fast machine. Labs can run more than 1,000 samples per qPCR instrument in 24 hours, the firm said.

ChromaCode Co-founder, President, and CEO Greg Gosch added in a statement that the firm "guarantees ongoing supply for customers who sign an agreement" with it. Later this year, the firm said it will launch a SARS-CoV-2 test combining multiple respiratory viruses into a single test in preparation for the upcoming flu season. 

According to the Carlsbad, California-based company, it uses data science technology and cloud-computing algorithms to boost performance of common molecular diagnostic instruments and reagents, and its high-definition PCR technology expands the number of detectable disease targets in a single reaction.

Last month, the firm announced it had raised a total of $38 million in a Series C financing round, which it will use to continue developing the HDPCR platform and further its global expansion in resource-limited communities.

The Scan

Transplant Tests Edited Pig Kidneys

The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient.

UK Changes Some Gene-Edited Crop Rules

A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says.

Pill Works Against Omicron in Lab

Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports.

Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas

In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.